At the news
? BULLISHIMPACT 8/10 CLUSTER filed Mar 5, 2026 at 19:00 ET
Two funds affiliated with ARCH Venture Partners collectively purchased nearly $25 million worth of Lyell Immunopharma shares in open-market transactions at $25.61 per share. This represents a significant, coordinated investment by a major biotech venture firm, signaling strong confidence in the company's future prospects.
- ARCH Venture Partners IX, LLC purchased 488,090 shares at $25.61 for $12,500,000
- ARCH Venture Fund XIII, L.P. purchased 488,090 shares at $25.61 for $12,500,000
- Total open-market purchases: $25.0M across two affiliated funds
- Transactions occurred on 2026-03-06 in a single day
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access